ETH-CAT: Difference between revisions

>Pharmreduction
m analoge act source
>Dextromethorphan
Pharmacology: added note fom a book im reading
Line 16: Line 16:


==Pharmacology==
==Pharmacology==
Although the effects of ETH-CAT have not been formally studied on the same level as traditional [[amphetamines]] or other substituted cathinones like [[methcathinone]], it is possible to speculate that like other simple [[substituted cathinone]], it most likely acts principally as a [[dopamine]] and [[norepinephrine]] [[reuptake inhibitor]].<ref>Kelly, J. P. (2011). Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. ''Drug Testing and Analysis'', 3(7‐8), 439-453. https://doi.org/10.1002/dta.31</ref>  
Although the effects of ETH-CAT have not been formally studied on the same level as traditional [[amphetamines]] or other substituted cathinones like [[methcathinone]], it is possible to speculate that like other simple [[substituted cathinone]], it most likely acts principally as a [[dopamine]] and [[norepinephrine]] [[reuptake inhibitor]].<ref>Kelly, J. P. (2011). Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. ''Drug Testing and Analysis'', 3(7‐8), 439-453. https://doi.org/10.1002/dta.31</ref> It however has been shown that ETH-CAT is a selective substrate for the norepinephrine transporter (NET).<ref>Phenethylamine - Von der Struktur zur Funktion, chapter 3.5</ref><ref>R. B. Rothmann, M. H. Baumann, Curr, Top, Med, Chem. 2006, 6, 1845</ref>


The result of this is an effective increase in the levels of [[catecholamine]] [[neurotransmitters]] like [[dopamine]] and [[norepinephrine]] in the brain by binding to and partially blocking the transporter proteins that normally clear these neurotransmitters from the synaptic cleft. This enables dopamine and norepinephrine to accumulate between the [[synaptic cleft|synaptic clefts]] of key regions of the brain associated with reward, motivation, satisfaction and pleasure to extra-endogenous levels. This mechanism is thought to account for the [[Stimulation|stimulating]], [[Motivation enhancement|motivation enhancing]] and [[Euphoria|euphoric]] effects that this substance produces.
The result of this is an effective increase in the levels of [[catecholamine]] [[neurotransmitters]] like [[dopamine]] and [[norepinephrine]] in the brain by binding to and partially blocking the transporter proteins that normally clear these neurotransmitters from the synaptic cleft. This enables dopamine and norepinephrine to accumulate between the [[synaptic cleft|synaptic clefts]] of key regions of the brain associated with reward, motivation, satisfaction and pleasure to extra-endogenous levels. This mechanism is thought to account for the [[Stimulation|stimulating]], [[Motivation enhancement|motivation enhancing]] and [[Euphoria|euphoric]] effects that this substance produces.